Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Ward, Alison K.
Smith, Shari E.
Just, Natasha A.
Vizeacoumar, Frederick S.
Vizeacoumar, Franco J.
Carlsen, Svein A.
Anderson, Deborah H.
Funding for this research was provided by:
Canadian Institutes of Health Research (CA) (MOP-137154)
Saskatchewan Cancer Agency
unspecified valid from 2016-01-25